NHS Logo

Natural Product Based Drug Discovery Against Human Parasites (Record no. 103855)

MARC details
000 -LEADER
fixed length control field 05675nam a22005055i 4500
001 - CONTROL NUMBER
control field 978-981-19-9605-4
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240821195203.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 231127s2023 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789811996054
-- 978-981-19-9605-4
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSGH
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code SCI045000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSG
Source thema
245 10 - TITLE STATEMENT
Title Natural Product Based Drug Discovery Against Human Parasites
Subtitle : Opportunities and Challenges /
250 ## - EDITION
Edition statement 1st ed. 2023.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Singapore :
Name of producer, publisher, distributor, manufacturer Springer Nature Singapore :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2023.
300 ## - PHYSICAL DESCRIPTION
Physical description XIX, 596 p. 1 illus.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - CONTENTS
Contents Chapter 1. Recent advances on the discovery of plants derived bioactive scaffolds/extracts against parasitic diseases -- Chapter 2. Applications of Computational Methods in Natural Products based Drug Discovery -- Chapter 3. Natural Product-Based Drug Designing for treatment of Human parasitic diseases -- Chapter 4. Secondary Metabolites of Plant Origin in Parasitic manifestations -- Chapter 5. Exploring marine biodiversity as alternative resources for treatment of Human Parasitic Diseases -- Chapter 6. Marine Bioprospecting for the Treatment of Human Parasitic Diseases -- Chapter 7. Microorganisms-Derived Biochemicals: Potential Drugs for Human Parasitic Diseases -- Chapter 8. Plant-Based Vaccines against Human Parasitic Diseases -- Chapter 9. Nanotechnology: its usages in drug delivery for the treatment of Human Parasitic Diseases -- Chapter 10. Therapeutic Potential Of Benzopyrones Against Antiparasitic Diseases -- Chapter 11. Antimicrobial peptides (AMPs): current state and future prospectsfor the treatment of human parasitic diseases -- Chapter 12. Pathway To Register Natural Product-Derived Therapeutics -- Chapter 13. Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future -- Chapter 14. Strategies and challenges for developing plant-based therapeutics against Protozoans -- Chapter 15. Recent approaches to combat toxoplasma gondii with plant-derived alternatives -- Chapter 16. Target-based rational improvement strategies and pitfalls in Leishmania drug discovery -- Chapter 17. Versatile Structurally Diverse Natural Products and Their Semisynthetic Analogs as Potential Anti-leishmanial Drugs -- Chapter 18. Promising compounds of plant origin and their synthetic analogs against Trypanosomes -- Chapter 19. Pathogenesis and Immune Response inT. cruzi infection: Quest for Natural compound-based drugs -- Chapter 20. Limitations of current drugs and prospects of plant-based compounds and their constructed analogues as therapeutics for treatment of malaria -- Chapter 21. An Analytical Approach to Progression in Malaria Therapeutics -- Chapter 22. Malaria Drug Discovery: How to tackle the problem of Drug Resistance -- Chapter 23. Approaches to drug discovery against Ascariasis: Opportunity and challenges in plant-based products -- Chapter 24. The Potential of Plant Secondary Metabolites as Drugs or Leads Against Helminths -- Chapter 25. Drug Resistance in Helminth parasites: Role of plant based natural therapeutics -- Chapter 26. Schistosomiasis: current and future strategies to develop novel therapeutics.
520 ## - ABSTRACT
Abstract This book comprehensively reviews current and novel treatment strategies against human parasites, including protozoans and helminths, using natural products. The initial chapters summarize the conventional treatment strategies and natural-product based therapeutics against these parasites. It discusses biochemical tools and techniques for the discovery of natural product based drugs against human parasites. The book also covers the ingenious and innovative mechanisms to achieve drug resistance by the protozoan parasites and strategies to overcome the resistance. It entails mechanistic insight into the modulation of host immune responses to delay or inhibit parasite clearance and explores host-pathogen interactions that mediate immunity against subsequent parasite challenge. In turn, the volume helps in understanding the immunobiology of the parasites and tools to identify candidate vaccine antigens and novel delivery systems against the protozoan parasites. Lastly, it explores the roleof advanced methods, including nanotechnology, marine bioprospecting, and microorganisms-derived biochemicals against the protozoan parasites. This book is useful for students and researchers of pharmacology, parasitology, zoology and other allied fields.
650 #0 - SUBJECT HEADINGS
Subject term Parasitology.
9 (RLIN) 7319
650 #0 - SUBJECT HEADINGS
Subject term Medical microbiology.
650 #0 - SUBJECT HEADINGS
Subject term Pharmacology.
9 (RLIN) 7400
650 #0 - SUBJECT HEADINGS
Subject term Drugs
General subdivision Design.
650 14 - SUBJECT HEADINGS
Subject term Parasitology.
9 (RLIN) 7319
650 24 - SUBJECT HEADINGS
Subject term Medical Microbiology.
650 24 - SUBJECT HEADINGS
Subject term Pharmacology.
9 (RLIN) 7400
650 24 - SUBJECT HEADINGS
Subject term Structure-Based Drug Design.
700 1# - ADDED PERSONAL NAME
Added personal author Singh, Archana.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Rathi, Brijesh.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Verma, Anita K.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Singh, Indrakant K.
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SBL
912 ## -
-- ZDB-2-SXB
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer BiomedLifeSc_2023   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-981-19-9605-4 02/05/2024 Electronic book